Implementation of guidelines for seasonal allergic rhinitis: a randomized controlled trial. - Wikidata - wikimedia - TriplyDB

Implementation of guidelines for seasonal allergic rhinitis: a randomized controlled trial.

Implementation of guidelines for seasonal allergic rhinitis: a randomized controlled trial.

http://www.wikidata.org/entity/Q44512144

about

Role of bilastine in the management of allergic rhinitis and urticaria: an Asia-Pacific consensus statement Sublingual immunotherapy in allergic rhinitis: efficacy, safety, adherence and guidelines Review of Desloratadine Data Using the ARIA Guidelines.Evaluation of patients' expectations and benefits in the treatment of allergic rhinitis with a new tool: the patient benefit index - the benefica study.Reassessing the evidence hierarchy in asthma: evaluating comparative effectiveness.The use of three strategies to improve quality of care at a national level.Optimal management of allergic rhinitis.Effect of catgut implantation at acupoints for the treatment of allergic rhinitis: a randomized, sham-controlled trial Attitudes, practices on allergic rhinitis of generalists and specialists in Philippine National Capital Region Promise and perils of guidelines in quality cancer care.Allergic rhinitis and its impact on otorhinolaryngology.Pharmacologic and anti-IgE treatment of allergic rhinitis ARIA update (in collaboration with GA2LEN).'Help for Hay Fever', a goal-focused intervention for people with intermittent allergic rhinitis, delivered in Scottish community pharmacies: study protocol for a pilot cluster randomized controlled trial A two-year course of specific immunotherapy or of continuous antihistamine treatment reverse eosinophilic inflammation in severe persistent allergic rhinitis Montelukast in the management of allergic rhinitis Role of antioxidants on the clinical outcome of patients with perennial allergic rhinitis.Criteria to screen for chronic sinonasal disease.Intranasal steroids in the treatment of allergy-induced rhinorrhea.How to design and evaluate randomized controlled trials in immunotherapy for allergic rhinitis: an ARIA-GA(2) LEN statement.Prevalence and diversity of allergic rhinitis in regions of the world beyond Europe and North America.Severe chronic allergic (and related) diseases: a uniform approach--a MeDALL--GA2LEN--ARIA position paper.Quality of life and control of allergic rhinitis in patients from regions beyond western Europe and the United States.MACVIA-ARIA Sentinel NetworK for allergic rhinitis (MASK-rhinitis): the new generation guideline implementation.The burden of allergic rhinitis (AR) in Canada: perspectives of physicians and patients.Lipid-based Nose Ointment for Allergic Rhinitis.Impact of pretreatment nasal symptoms on treatment outcome in allergic rhinitis.Visual analogue scale in patients treated for allergic rhinitis: an observational prospective study in primary care: asthma and rhinitis.Clinically relevant effect of a new intranasal therapy (MP29-02) in allergic rhinitis assessed by responder analysis.RCAT reflects symptom control and quality of life in allergic rhinoconjunctivitis patients.Acute and chronic rhinosinusitis and allergic rhinitis in relation to comorbidity, ethnicity and environment.Impact of allergic rhinitis symptoms on quality of life in primary care.Specialist-based treatment reduces the severity of allergic rhinitis.Health-related quality of life in allergic rhinitis: comparing the short form ESPRINT-15 and MiniRQLQ questionnaires.Classification and management of allergic rhinitis patients in general practice during pollen season.Once daily fluticasone furoate nasal spray is effective in seasonal allergic rhinitis caused by grass pollen.Standardized training for healthcare professionals and its impact on patients with perennial rhinitis: a multi-centre randomized controlled trial.MicroRNA-let-7e regulates the progression and development of allergic rhinitis by targeting suppressor of cytokine signaling 4 and activating Janus kinase 1/signal transducer and activator of transcription 3 pathway.Sub-lingual immunotherapy: world allergy organization position paper 2009.Visual analogue scales (VAS): Measuring instruments for the documentation of symptoms and therapy monitoring in cases of allergic rhinitis in everyday health care: Position Paper of the German Society of Allergology (AeDA) and the German Society of A Allergic rhinitis

P2860

Q26769045-81290B03-B107-41D4-BE85-30E508C47236 Q27002341-18A26523-BB42-4BCA-AF54-2FE5B942BC12 Q30583273-9E65BB05-8E45-42C4-865C-97799D4767D1 Q35146166-BDBA7054-72A1-4C66-88FB-DF8D012E7218 Q35523534-DF0790E0-09D1-4DE5-B54C-EE98A36BF6C5 Q35802896-A3FF78F3-54AA-4B1D-BCEB-D199D0608377 Q35888881-DF5F4DA3-4299-4175-AE04-214E5278B862 Q36187922-8534B3F1-C551-4A77-837A-EE4966135DC6 Q36241661-3E5BB882-0572-4C20-8159-F5220175030A Q36406080-88608EFF-0C97-4F54-BFC6-740F221A1E4E Q36469365-425C30D9-E056-45E7-A179-38566F4C8DB3 Q36570549-D444BE4F-B643-4319-BAEE-172EA58F1E0E Q37042147-544CBCB1-3795-45C4-B4AF-09AC06FCF01F Q37091858-03E1288A-AE34-47A3-80EF-258B17CA3740 Q37116842-81104C43-68DC-4FDE-B8AF-D3D26935878F Q37230372-1EEA05DD-4F55-4474-888C-BEC769E5AAD2 Q37411996-9077E2E7-3131-40BD-B836-7944AF7DD30A Q37761859-237C3EC1-D376-4DEF-B4CF-1430101FB3C8 Q37865584-B0840666-3FE9-42A1-8C50-EFD7B7815BF2 Q37957287-9FAFE1A7-9FF4-4BAF-9929-5CE2C087E0AD Q37989857-07570C00-E9B7-4003-8005-80DD53ED8718 Q38062585-C79F0CF8-8DD0-42A4-B4ED-483628B5B624 Q38543189-AF85BFFC-9A09-47EF-8E50-23E292D39EA4 Q39246987-61BDBAF9-8A3F-4ABB-B5E9-32F0A37FDB11 Q39735590-F4D99567-65E3-407F-B841-14324B10A41D Q43155435-6009022E-CD44-4A87-8C9A-9B509EB7DD2E Q44794327-C0DEB3AB-7C2F-4230-B045-D86ABD3513E4 Q44800324-4B044CAF-1915-4649-B100-70A146D97B44 Q47437151-65E69EC5-6258-41F8-AA22-B70CB31BDF53 Q48105510-61A475C8-BE44-448C-A835-AA7C326A098A Q48209846-FB71569C-C601-47C1-A984-FE5511ECD47F Q48221811-EF7C1C5A-725D-47B8-9C58-4EED9AE1BA6F Q48452444-B6EAD7D5-DAF1-4661-B7D4-1DB850164AEF Q49084611-BBDE637D-F46D-4FB0-8C78-41ABDB3FFF54 Q50940308-340D16F4-64DF-4082-A165-39468E1DCABE Q53210230-E7E5AA9C-977B-4E3E-80BB-9514DF0AB0D4 Q54982085-1CC86700-262B-4283-A5AF-0CF1EE3AAC53 Q55527154-60E46920-F8F3-4CC5-81D1-F7C4C8E26FB8 Q56971253-E0AFFB27-337C-42EC-972E-64EFBE035C9C Q58745869-B4092BB8-33DC-4B59-8640-BFA5714C7844

P2860

Implementation of guidelines for seasonal allergic rhinitis: a randomized controlled trial.

http://www.wikidata.org/entity/Q44512144

description

2003 nî lūn-bûn

@nan

2003年の論文

@ja

2003年学术文章

@wuu

2003年学术文章

@zh-cn

2003年学术文章

@zh-hans

2003年学术文章

@zh-my

2003年学术文章

@zh-sg

2003年學術文章

@yue

2003年學術文章

@zh

2003年學術文章

@zh-hant

name

Implementation of guidelines f ...... a randomized controlled trial.

@en

Implementation of guidelines f ...... a randomized controlled trial.

@nl

type

label

Implementation of guidelines f ...... a randomized controlled trial.

@en

Implementation of guidelines f ...... a randomized controlled trial.

@nl

prefLabel

Implementation of guidelines f ...... a randomized controlled trial.

@en

Implementation of guidelines f ...... a randomized controlled trial.

@nl

P1433

Q44512144-25F00C3C-3B7B-4DDC-8BEE-F861C362D5DF

P1476

Q44512144-9C54B7B1-3549-4AD2-98EF-C14E7EB81648

P2093

Q44512144-1979861D-1BAD-41FB-8492-20728E9E43DB

Q44512144-3B614A5B-DCCD-44CB-B97B-A2FB76734845

Q44512144-4E2A0F43-931A-48BD-A99E-395FCEC7D733

Q44512144-50D28423-5AB7-4C5A-9B82-8B13E49E78F1

Q44512144-5D4B7C6E-3D98-4059-B98F-36276DA4170C

Q44512144-78047E7A-158B-4126-A479-43A8C22983BE

Q44512144-CC4C7357-6298-450F-828F-5160EAA294B4

P2860

Q44512144-395B9304-D9E7-445A-BF51-6DCAC1E5979F

Q44512144-443DFFEC-72A1-482F-8DFB-DD2F2B124562

Q44512144-5A862F27-CE5A-41D6-B0B6-33D6C15EC4C0

Q44512144-62BACC00-FB95-45E8-AF5A-35F5F51C56AD

Q44512144-A68159F9-A065-4A28-A5E2-8B441AAA7B89

Q44512144-C6EBFF79-849D-49F9-B47C-5DFA8E1960BC

Q44512144-CFB04185-1389-470B-99A9-1F166C6D38E0

Q44512144-D1A08069-63F3-4D94-A28E-8C864F399C6C

Q44512144-D1C72EF0-DFF7-435C-9EA6-BC191A5AA849

Q44512144-F77D1CD7-315A-4F4F-8016-39BD51FD734C

P304

Q44512144-23A2E7F6-DF36-4BA4-931B-1E127FB869EB

P31

Q44512144-47680F48-F237-47D6-9975-E35C8E9729FB

P356

Q44512144-D6224AAE-D1DD-4128-80A6-BDAE5954E646

P433

Q44512144-1A44BE62-D18D-4266-8200-4C762AC18FAE

P478

Q44512144-446C2EAC-5823-4633-BF4B-B3B28E8ABBE5

P577

Q44512144-EEDC3AFF-DC58-4971-8974-69B520B1BE13

P5875

Q44512144-FB328D1E-513F-4E15-93D9-7DE20E4C81ED

P698

Q44512144-F1BF5F43-885B-48E1-BE0C-C5CF17CF1C8C

P356

J.1398-9995.2003.00076.X

P1433

P1476

Implementation of guidelines f ...... a randomized controlled trial.

@en

P2093

Bousquet J

http://www.w3.org/2001/XMLSchema#string

Bremard-Oury C

http://www.w3.org/2001/XMLSchema#string

El-Akkad T

http://www.w3.org/2001/XMLSchema#string

Lund VJ

http://www.w3.org/2001/XMLSchema#string

Mounedji N

http://www.w3.org/2001/XMLSchema#string

Stevens MT

http://www.w3.org/2001/XMLSchema#string

van Cauwenberge P

http://www.w3.org/2001/XMLSchema#string

P2860

Clinical guidelines: potential benefits, limitations, and harms of clinical guidelines

Intranasal corticosteroids versus oral H1 receptor antagonists in allergic rhinitis: systematic review of randomised controlled trials.

A revised nomenclature for allergy. An EAACI position statement from the EAACI nomenclature task force.

A double-blind placebo-controlled study of the efficacy and tolerability of ebastine against hayfever in general practice patients.

The pharmacology and use of H1-receptor-antagonist drugs.

Guidelines for clinical guidelines.

Effects of budesonide and fluticasone propionate in a placebo-controlled study on symptoms and quality of life in seasonal allergic rhinitis.

Consensus statement on the treatment of allergic rhinitis. European Academy of Allergology and Clinical Immunology.

Determining a minimal important change in a disease-specific Quality of Life Questionnaire.

Generic and specific measurement of health-related quality of life in a clinical trial of respiratory rehabilitation.

P304

733-741

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1034/J.1398-9995.2003.00076.X

http://www.w3.org/2001/XMLSchema#string

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

58

http://www.w3.org/2001/XMLSchema#string

P577

2003-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

10661997

http://www.w3.org/2001/XMLSchema#string

P698

12859551

http://www.w3.org/2001/XMLSchema#string